XML 55 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Significant Accounting Policies [Abstract] |
Schedule of Property and Equipment on Straight-Line Basis Over Useful Life of Assets | Depreciation is calculated on a straight-line basis over the useful life of the assets at annual rates as follows:
|  | % |
Office furniture and equipment |  |  | 7 - 20 |
Computer and peripheral equipment |  |  | 33 |
Machinery and equipment |  |  | 7 - 33 |
Equipment on lease (*) |  |  | 14 |
Leasehold improvements |  |  | (**) |
Building and land |  |  | (***) |
(*) | Equipment on lease is stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful life of the equipment on lease, which was determined to be 7 years.
(**) | Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term (including the extension option held by the Company and intended to be exercised) and the expected life of the improvement.
(***) | Building and land consist of land and an ink manufacturing plant. In September 2018, the Company purchased the land which includes long-term leasehold rights, with a lease term of 49 years, which may be renewed for an additional 49 years. The manufacturing plant useful life is 25 years.
Schedule of Remaining Performance Obligations | The aggregate amount of transaction price allocated to the remaining performance obligations was $4,422 as of December 31, 2024, which are expected to be satisfied and recognized in future periods as represented in the following table:
|  | 2025 |  |  | 2026 |  |  | 2027 and thereafter |
Service contracts and software subscriptions |  | $ | 4,404 |  |  | $ | 18 |  |  | $ | - |
Schedule of Changes in Liability for Product Warranty | The following are the changes in the liability for product warranty from January 1, 2023 to December 31, 2024:
Balance at January 1, 2023 |  | $ | 1,918 |
Additions and adjustments to cost of revenues |  |  | 2,492 |
Reduction for payments and costs to satisfy claims |  |  | (3,087 | )
Balance at December 31, 2023 |  | $ | 1,323 |
Additions and adjustments to cost of revenues |  |  | 1,761 |
Reduction for payments and costs to satisfy claims |  |  | (2,032 | )
Balance at December 31, 2024 |  | $ | 1,052 |
Schedule of Fair Value Method for Stock Options Awards | The Company selected the binomial option pricing model as the most appropriate fair value method for its stock options awards with the following assumptions for the years ended December 31, 2024, 2023 and 2022:
|  | Year ended December 31,
|  | 2024 |  | 2023 |  | 2022
Suboptimal exercise multiple |  | 2.8 |  | 2.8 |  | 2.8
Risk free interest rate |  | 4.01%-3.82% |  | 4.26%-4.30% |  | 3.02%-4.09%
Volatility |  | 58.29%-62.88% |  | 57.75%-60.75% |  | 58.67%-69.13%
Dividend yield |  | 0% |  | 0% |  | 0%
Schedule of Notional Amounts of Outstanding Derivative Positions | The following table summarizes the notional amounts for hedged items:
|  | December 31, |
|  | 2024 |  |  | 2023 |
Designated cash flow hedges |  |  | - |  |  | $ | 38,465 |
Non-designated hedges |  |  | - |  |  |  | 491 |
|  |  | - |  |  | $ | 38,956 |
Schedule of Expense (Income) from Derivatives Instruments | The following table sets forth the expense (income) from derivatives instruments included in the consolidated statements of operations and reclassified from other comprehensive income:
|  | Year ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
Cost of revenues |  | $ | (105 | ) |  | $ | 814 |  |  | $ | 674 |
Research and development |  |  | (240 | ) |  |  | 1,144 |  |  |  | 1,029 |
Sales and marketing |  |  | (63 | ) |  |  | 368 |  |  |  | 365 |
General and administrative |  |  | (96 | ) |  |  | 548 |  |  |  | 481 |
Schedule of Restructuring Charges | A summary of the restructuring charges for the year ended December 31, 2024 and 2023 by major activity type is as follows:
|  | December 31, 2024 |
|  | Employee termination costs |  |  | Write-off |  |  | Others |  |  | Total |
Cost of product revenues |  | $ | 894 |  |  | $ | 789 |  |  | $ | - |  |  | $ | 1,683 |
Cost of service revenues |  |  | 298 |  |  |  | - |  |  |  | - |  |  |  | 298 |
Research and development |  |  | 235 |  |  |  | - |  |  |  | - |  |  |  | 235 |
Sales and marketing |  |  | 190 |  |  |  | - |  |  |  | - |  |  |  | 190 |
General and administrative |  |  | 437 |  |  |  | - |  |  |  | - |  |  |  | 437 |
|  | $ | 2,054 |  |  | $ | 789 |  |  | $ | - |  |  | $ | 2,843 |
|  | December 31, 2023 |
|  | Employee termination costs |  |  | Write-off |  |  | Others |  |  | Total |
Cost of product revenues |  | $ | 147 |  |  | $ | 5,510 |  |  | $ | - |  |  | $ | 5,657 |
Cost of service revenues |  |  | 433 |  |  |  | 5,499 |  |  |  | - |  |  |  | 5,932 |
Research and development |  |  | 283 |  |  |  | 598 |  |  |  | - |  |  |  | 881 |
Sales and marketing |  |  | 719 |  |  |  | - |  |  |  | 2,211 |  |  |  | 2,930 |
General and administrative |  |  | 597 |  |  |  | 3,378 |  |  |  | - |  |  |  | 3,975 |
|  | $ | 2,179 |  |  | $ | 14,985 |  |  | $ | 2,211 |  |  | $ | 19,375 |

X
- Definition Tabular disclosure of property and equipment for useful life. + References No definition available. + Details
Name: | krnt_ScheduleOfPropertyAndEquipmentForUsefulLifeTableTextBlock
Namespace Prefix: | krnt_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the notional amounts of outstanding derivative positions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A + Details
Name: | us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8 + Details
Name: | us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration